Radiosynthesis, Preclinical, and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous Compounds

被引:11
|
作者
Shegani, Antonio [1 ]
Kealey, Steven [1 ]
Luzi, Federico [1 ]
Basagni, Filippo [2 ]
Machado, Joana do Mar [1 ]
Ekici, Sevban Dogan [1 ]
Ferocino, Alessandra [3 ]
Gee, Antony D. [1 ]
Bongarzone, Salvatore [1 ,4 ]
机构
[1] Kings Coll London, Sch Biomed Engn & Imaging Sci, Kings Hlth Partners, London SE1 7EH, England
[2] Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol, I-40126 Bologna, Italy
[3] Italian Natl Res Council, Inst Organ Synth & Photoreact, I-40129 Bologna, Italy
[4] Novartis Co, Tech Res & Dev Adv Accelerator Applicat, Via Ribes 5, I-10010 Colleretto Giacosa, Italy
基金
英国工程与自然科学研究理事会;
关键词
CEREBRAL PROTEIN-SYNTHESIS; BLOOD-BRAIN-BARRIER; HIGH-YIELD SYNTHESIS; IN-VIVO MEASUREMENT; SQUAMOUS-CELL CARCINOMA; CARRIER-ADDED SYNTHESIS; POTENTIAL PET TRACER; TNF-ALPHA PRODUCTION; MONOAMINE OXIDASE-A; TISSUE AMINO-ACIDS;
D O I
10.1021/acs.chemrev.2c00398
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The presence of positron emission tomography (PET) centers at most major hospitals worldwide, along with the improvement of PET scanner sensit i v i t y and the introduction of total body PET systems, has increased the interest in the PET tracer development using the short-lived radionuclides carbon-11. In the last few decades, methodological improvements and fully automated modules have allowed the development of carbon-11 tracers for clinical use. Radiolabeling natural compounds with carbon-11 by substituting one of the backbone carbons with the radionuclide has provided important information on the biochemistry of the authentic compounds and increased the understanding of their in vivo behavior in healthy and diseased states. The number of endogenous and natural compounds essential for human life is staggering, ranging from simple alcohols to vitamins and peptides. This review collates all the carbon-11 radiolabeled endogenous and natural exogenous compounds synthesised to date, including essential information on thei r radiochemistry methodologies and preclinical and clinical studies in healthy subjects.
引用
收藏
页码:105 / 229
页数:125
相关论文
共 50 条
  • [1] Radiosynthesis, Preclinical and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous Compounds (vol 13, pg 105, 2023)
    Shegani, Antonio
    Kealey, Steven
    Luzi, Federico
    Basagni, Filippo
    Machado, Joana do Mar
    Ekici, Sevban Dogan
    Ferocino, Alessandra
    Gee, Antony D.
    Bongarzone, Salvatore
    CHEMICAL REVIEWS, 2023, 123 (15) : 9718 - 9718
  • [2] Synthesis of Endogenous Compounds Labeled with 11C for Positron Emission Tomography
    Kilian, K.
    Pekal, A.
    ACTA PHYSICA POLONICA A, 2015, 127 (05) : 1475 - 1478
  • [3] Aluminum Fluoride-18 Labeled Mannosylated Dextran: Radiosynthesis and Initial Preclinical Positron Emission Tomography Studies
    Andriana, Putri
    Makrypidi, Konstantina
    Liljenbaeck, Heidi
    Rajander, Johan
    Saraste, Antti
    Pirmettis, Ioannis
    Roivainen, Anne
    Li, Xiang-Guo
    MOLECULAR IMAGING AND BIOLOGY, 2023, 25 (06) : 1094 - 1103
  • [4] Aluminum Fluoride-18 Labeled Mannosylated Dextran: Radiosynthesis and Initial Preclinical Positron Emission Tomography Studies
    Putri Andriana
    Konstantina Makrypidi
    Heidi Liljenbäck
    Johan Rajander
    Antti Saraste
    Ioannis Pirmettis
    Anne Roivainen
    Xiang-Guo Li
    Molecular Imaging and Biology, 2023, 25 : 1094 - 1103
  • [5] Carbon-11 Choline Positron Emission Tomography-Computed Tomography for HyperParathyroidism
    Kumar, Pratik
    JOURNAL OF MEDICAL PHYSICS, 2023, 48 (01) : 100 - 100
  • [6] Development and Characterization of a Novel Carbon-11 Labeled Positron Emission Tomography Radiotracer for Neuroimaging of Sirtuin 1 with Benzoxazine-Based Compounds
    Wang, Yanli
    Liu, Yan
    Wang, Yongle
    Bai, Ping
    Hallisey, Madelyn Rose
    Varela, Breanna Lizeth
    Siewko, Anne
    Wang, Changning
    Xu, Yulong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 819 - 827
  • [7] Experience with carbon-11 choline positron emission tomography in prostate carcinoma
    Kotzerke, J
    Prang, J
    Neumaier, B
    Volkmer, B
    Guhlmann, A
    Kleischmidt, K
    Hautmann, R
    Reske, SN
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (09) : 1415 - 1419
  • [8] Experience with carbon-11 choline positron emission tomography in prostate carcinoma
    Jörg Kotzerke
    Jürgen Prang
    Bernd Neumaier
    Björn Volkmer
    Albrecht Guhlmann
    Klaus Kleinschmidt
    Richard Hautmann
    Sven N. Reske
    European Journal of Nuclear Medicine, 2000, 27 : 1415 - 1419
  • [9] Radiosynthesis and preclinical evaluation of a carbon-11 labeled PET ligand for imaging metabotropic glutamate receptor 7
    Li, Yinlong
    Xiao, Zhiwei
    Mori, Wakana
    Sun, Jiyun
    Yamasaki, Tomoteru
    Rong, Jian
    Fujinaga, Masayuki
    Chen, Jiahui
    Kumata, Katsushi
    Zhao, Chunyu
    Zhang, Yiding
    Collier, Thomas L.
    Hu, Kuan
    Xie, Lin
    Zhou, Xin
    Zhang, Wei
    Song, Zhendong
    Gao, Yabiao
    Sun, Zhenkun
    Zhang, Kuo
    Patel, Jimmy S.
    Ran, Chongzhao
    Chaudhary, Ahmad
    Sheffler, Douglas J.
    Cosford, Nicholas D. P.
    Zhang, Linqi
    Zhai, Chuangyan
    Haider, Ahmed
    Yuan, Hongjie
    Zhang, Ming-Rong
    Liang, Steven H.
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 14 (05):
  • [10] Synthesis and Characterization of a New Carbon-11 Labeled Positron Emission Tomography Radiotracer for Orexin 2 Receptors Neuroimaging
    Wang, Yanli
    Wang, Yongle
    Liu, Yan
    Cheng, Hua
    Dagnew, Tewodros Mulugeta
    Xu, Yulong
    Wang, Changning
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 215 - 222